Actively Recruiting
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-09-04
256
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
L
Leiden University Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.
CONDITIONS
Official Title
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age at least 18 years
- Indication for elective left-sided pancreatectomy for proven or suspected benign or premalignant disease
- Both laparoscopic and robot-assisted left-sided pancreatectomy are technically feasible
- Fit to undergo left-sided pancreatectomy as judged by surgeon and anesthesiologist
- Written informed consent provided
You will not qualify if you...
- Suspected pancreatic ductal adenocarcinoma
- Tumor or cyst larger than 8 cm
- Need for resection or ablation of organs other than pancreas and spleen
- Tumor involvement or abutment of major vessels (celiac trunk, mesenteric artery, or vena cava)
- Pregnancy
- Body mass index greater than 40 kg/m2
- Participation in another study that could interfere with outcomes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Amsterdam UMC
Amsterdam, Netherlands
Actively Recruiting
Research Team
C
Charlotte Baggerman van Houweninge, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here